Revenue, last quarter
$0
−100% vs same quarter last year
Net income
−$5.9M
+23.7% vs same quarter last year
EPS, diluted
−$0.39
+53.6% vs same quarter last year
Operating cash flow
−$5.1M
+21.5% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $4M | −$27M |
| FY24 | $9.7M | −$16.3M |
| FY23 | $7.1M | −$2.2M |
| FY22 | $0 | - |
| FY21 | - | - |
| FY20 | - | - |
| FY19 | - | - |
| FY18 | - | - |
| FY17 | - | −$1.4M |
| FY16 | - | −$18M |
| FY15 | - | −$6.7M |
| FY14 | - | −$14.4M |
| FY13 | $71.7K | −$2.5M |
| FY12 | $374.5K | −$6.9M |
| FY11 | $570.5K | −$22.6M |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | - | −706.2% | −673.2% |
| FY24 | - | −187.2% | −167.3% |
| FY23 | - | −109.3% | −30.4% |
| FY22 | - | - | - |
| FY21 | - | - | - |
| FY20 | - | - | - |
| FY19 | - | - | - |
| FY18 | - | - | - |
| FY17 | - | - | - |
| FY16 | - | - | - |
| FY15 | - | - | - |
| FY14 | - | - | - |
| FY13 | 100% | −17855.5% | −3429.7% |
| FY12 | 37% | −3148.3% | −1833.9% |
| FY11 | −304.7% | −2879.9% | −3967.9% |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | - |
| FY24 | - |
| FY23 | - |
| FY22 | - |
| FY21 | - |
| FY20 | - |
| FY19 | - |
| FY18 | - |
| FY17 | −$12.8M |
| FY16 | −$10.8M |
| FY15 | −$5.2M |
| FY14 | −$9.1M |
| FY13 | - |
| FY12 | - |
| FY11 | - |
- CervoMed
- Healthcare median
Show the numbers
| Year | CervoMed | Healthcare median |
|---|---|---|
| FY25 | −673.2% | −30.6% |
| FY24 | −167.3% | −47% |
| FY23 | −30.4% | −58% |
| FY22 | - | −80.4% |
| FY21 | - | −71.9% |
| FY20 | - | −62.2% |
| FY19 | - | −46.3% |
| FY18 | - | −49.6% |
| FY17 | - | −45.9% |
| FY16 | - | −36% |
| FY15 | - | −38.4% |
| FY14 | - | −35.5% |
| FY13 | −3429.7% | −37.1% |
| FY12 | −1833.9% | −29.1% |
| FY11 | −3967.9% | −27.9% |